KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low-grade serous carcinoma

BRAF and KRAS mutations in ovarian serous borderline tumors (OSBTs) and ovarian low-grade serous carcinomas (LGSCs) have been previously described. However, whether those OSBTs would progress to LGSCs or those LGSCs were developed from OSBT precursors in previous studies is unknown. Therefore, we as...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tsang, Yvonne T., Deavers, Michael T., Sun, Charlotte C., Kwan, Suet-Yan, Kuo, Eric, Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4095747/
https://ncbi.nlm.nih.gov/pubmed/24549645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.4252
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires